PT-016 - POLYGENIC RISK SCORES FOR BLOOD PRESSURE MAY PREDICT RISK OF SEVERE BEVACIZUMAB-INDUCED HYPERTENSION IN CANCER PATIENTS.

J. Quintanilha¹, A. Etheridge¹, B. Graynor², H. Rugo³, H. Kindler⁴, W. Kevin Kelly⁵, N. Larson⁶, B. Mitchell⁷, F. Innocenti¹; ¹University of North Carolina at Chapel Hill, Chapel Hill, NC, USA, ²University of Maryland, College Park, MD, USA, ³University of California San Francisco, San Francisco, CA, USA, ⁴The University of Chicago, Chicago, IL, USA, ⁵Yale School of Medicine, New Haven, CT, USA, ⁶Mayo Clinic, Rochester, MN, USA, ⁷University of Maryland, Baltimore, MD, USA.